V
Vertex develops approved and investigational therapies across cystic fibrosis, sickle cell disease, beta thalassemia, pain, and rare kidney diseases. The hiring profile skews heavily toward commercial and sales roles (310 active), with substantial director-level seniority (153 roles), signaling post-launch scaling across marketed assets. Active projects cluster around formulary implementation, territory planning, and JournaVX adoption, while pain points reflect mature market access challenges: stocking pull-through, regulatory compliance, and formulary inclusion.
Tech Stack 81 technologies
Core StackSAS Python Tableau Power BI Salesforce Jira Snowflake Marketo Azure AD GitHub Copilot Oracle EBS Blackline Hyperion Essbase PowerPoint Excel Word R SQL IQVIA Veeva CRM Veeva EDI Veeva Align Concur Salesforce Marketing Cloud Tealium Acquia Microsoft Purview Microsoft Defender for Cloud Apps Microsoft 365 Security & Compliance Center+51 more
What Vertex Pharmaceuticals Is Building
◆Challenges
- Implementing inpatient formularies
- Ensuring stocking and managed care pull through
- Driving adoption of new drug
- Ensuring compliance with regulatory requirements
- Ensuring formulary inclusion
- Inspection readiness
- Access barriers
- Optimizing team performance
- Rare kidney disease market dynamics
- Improving training efficiency
▲Active Projects
- Implementing inpatient formularies
- Launch readiness
- Develop strategic account plans
- Strategic territory business plans
- Implementing inpatient formularies, protocols, pathways, and order sets
- Driving adoption of journavx
- Technology transfer to cdmos
- Ai strategy roadmap
- Life cycle management (lcm) plans
- Medical affairs strategy implementation
Hiring Activity
650 roles · 290 in 30d
Department
Seniority
Notable leadership hires: Data Analytics Director, Commercial Strategy Director, Market Access Director, Innovation Director, Strategy Director
Company intelligence
